HeraMED Limited (ASX:HMD)
Australia · Delayed Price · Currency is AUD 0.0340
-0.0010 (-2.86%)
Sep 15, 2025, 10:24 AM AEST
HeraMED Market Cap
HeraMED has a market cap or net worth of 35.40 million as of September 15, 2025. Its market cap has increased by 143.02% in one year.
Market Cap
35.40M
Enterprise Value
34.44M
Revenue
322.93K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
Market Cap Chart
Since December 12, 2018, HeraMED's market cap has increased from 15.76M to 35.40M, an increase of 124.66%. That is a compound annual growth rate of 12.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 35.40M | 102.12% |
| Dec 31, 2024 | 17.51M | 127.12% |
| Dec 29, 2023 | 7.71M | -74.58% |
| Dec 30, 2022 | 30.33M | -32.86% |
| Dec 31, 2021 | 45.18M | 173.72% |
| Dec 31, 2020 | 16.50M | -0.06% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 100.64B |
| Pro Medicus | 31.19B |
| Cochlear | 19.61B |
| Sonic Healthcare | 11.19B |
| Ramsay Health Care | 7.72B |
| Ansell | 4.89B |
| Telix Pharmaceuticals | 4.63B |
| Mesoblast | 2.83B |